Share Repurchases	12 Months Ended
Dec. 31, 2022
Equity [Abstract]
Share Repurchases	Share RepurchasesIn 2018, our Board of Directors authorized a share repurchase program, which allows us to purchase up to $300.0 million of our common stock through open market repurchases, negotiated transactions, or other means, in accordance with applicable securities laws and other restrictions. This program is funded with cash on hand and cash flows from operating activities. During 2020, we repurchased 1.0 million shares of our common stock for an aggregate cost of $35.0 million at an average price per share of $35.83. During 2021, we did not repurchase shares of our common stock. During 2022, we repurchased 2.6 million shares of our common stock for an aggregate cost of $150.0 million at an average price per share of $57.95. From inception of our program, we have repurchased 4.5 million shares of our common stock for an aggregate cost of $235.0 million and an average price of $52.75. As of December 31, 2022, we had $65.0 million of authorizations remaining under the program.

Share Repurchases

12 Months Ended

Dec. 31, 2022

Share RepurchasesIn 2018, our Board of Directors authorized a share repurchase program, which allows us to purchase up to $300.0 million of our common stock through open market repurchases, negotiated transactions, or other means, in accordance with applicable securities laws and other restrictions. This program is funded with cash on hand and cash flows from operating activities. During 2020, we repurchased 1.0 million shares of our common stock for an aggregate cost of $35.0 million at an average price per share of $35.83. During 2021, we did not repurchase shares of our common stock. During 2022, we repurchased 2.6 million shares of our common stock for an aggregate cost of $150.0 million at an average price per share of $57.95. From inception of our program, we have repurchased 4.5 million shares of our common stock for an aggregate cost of $235.0 million and an average price of $52.75. As of December 31, 2022, we had $65.0 million of authorizations remaining under the program.